MARKET

AVXL

AVXL

Anavex Life Scie
NASDAQ
3.680
+0.120
+3.37%
After Hours: 3.710 +0.03 +0.82% 19:28 01/02 EST
OPEN
3.630
PREV CLOSE
3.560
HIGH
3.710
LOW
3.495
VOLUME
1.55M
TURNOVER
--
52 WEEK HIGH
14.25
52 WEEK LOW
2.860
MARKET CAP
328.80M
P/E (TTM)
-6.7672
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AVXL last week (1222-1226)?
Weekly Report · 12/29/2025 10:08
Anavex Life Sciences Price Target Maintained With a $20.00/Share by HC Wainwright & Co.
Dow Jones · 12/22/2025 10:41
Weekly Report: what happened at AVXL last week (1215-1219)?
Weekly Report · 12/22/2025 10:07
Anavex Life Sciences Is Maintained at Buy by D. Boral Capital
Dow Jones · 12/19/2025 15:28
Anavex Life Sciences Price Target Maintained With a $24.00/Share by D. Boral Capital
Dow Jones · 12/19/2025 15:28
D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $24 Price Target
Benzinga · 12/19/2025 15:18
Anavex asks EMA to re-examine its negative opinion on blarcamesine for Alzheimer's
Seeking Alpha · 12/18/2025 17:55
Anavex Life Sciences Requests European Medicines Agency To Re-Examine Its Opinion On Blarcamesine For Treatment Of Early Alzheimer's Disease
Benzinga · 12/18/2025 12:36
More
About AVXL
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with high unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which it uses in the analysis of its clinical trials. Its focus is on developing treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other CNS disorders. It has two core programs and two seed programs. ANAVEX 2-73 is being developed as an oral liquid once-daily formulation for rare diseases such as Rett syndrome as well as an oral once-daily capsule formulation for diseases such as Alzheimer’s disease. ANAVEX 3-71 is a CNS-penetrable potential disease-modifying treatment for cognitive impairments. Its other candidates include ANAVEX 1-41, ANAVEX 1066 and ANAVEX 1037.

Webull offers Anavex Life Sciences Corp stock information, including NASDAQ: AVXL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVXL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVXL stock methods without spending real money on the virtual paper trading platform.